Nicotine Replacement for Smokers
Study Summary
This trial looks at how well cancer patients are able to quit smoking when given a smoking cessation treatment plan delivered online or over the phone.
- Current Smokers
- Tumors
- Cancer
- Carcinoma
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
How many participants are the researchers limiting this research to?
"This clinical trial requires 418 suitable participants. Those looking to take part can do so at the Prisma Health Cancer Institute - Spartanburg in South Carolina and/or the Prisma Health Cancer Institution - Butternut situated in Greenville, Minnesota."
How many medical facilities have implemented this research?
"This clinical trial is presently open for enrollment at 38 medical sites. These locations are spread across Spartanburg, Greenville and Seneca as well as other cities around the United States of America. To reduce your travel commitment, it's important to select a site close by when enrolling."
Has the FDA sanctioned any Nicotine Replacement therapies?
"Considering the Phase 2 status of this clinical trial, there is evidence to suggest nicotine replacement therapy's safety but no proof that it works. Therefore, we gave it a score of 2 on our scale from 1-3."
Are there vacancies available for prospective test subjects in this experiment?
"According to information located on clinicaltrials.gov, this medical experiment is currently enrolling participants. Since its initial posting on April 11th 2019, it has been regularly updated as recently as November 15th 2022."
Are there any prior investigations into Nicotine Replacement therapies?
"In 2006, the University of Hong Kong began studying nicotine replacement therapy. After 557 completed studies, there are presently 71 ongoing clinical trials across Spartanburg, South Carolina and beyond that focus on this particular area of research."